Gyeonggi-do, South Korea

Ka Eun Lee

USPTO Granted Patents = 3 

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2021-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Ka Eun Lee in Neurological Treatments

Introduction

Ka Eun Lee is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurological diseases. With a total of three patents to his name, Lee's work focuses on innovative compounds that offer new therapeutic options.

Latest Patents

Among his latest patents, Lee has developed compounds having oxadiazole and pharmaceutical compositions containing the same. These oxadiazole compounds and their pharmaceutically acceptable salts are specifically designed for the treatment of neurological diseases such as epilepsy. This innovation represents a promising advancement in the pharmaceutical industry, potentially improving the quality of life for patients suffering from these conditions.

Career Highlights

Ka Eun Lee is currently associated with SK Biopharmaceuticals Co., Ltd., a company known for its commitment to developing innovative treatments. His work at the company has been instrumental in advancing research and development in the field of neurology.

Collaborations

Lee collaborates with talented professionals in his field, including Choon Ho Ryu and Min Soo Han. These partnerships enhance the research efforts and contribute to the successful development of new pharmaceutical solutions.

Conclusion

Ka Eun Lee's contributions to the field of pharmaceuticals, particularly through his innovative oxadiazole compounds, highlight his role as a key inventor in the treatment of neurological diseases. His work continues to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…